Statin therapy and the incidence of atherosclerotic cardiovascular events after kidney transplantation.
Charifa NazoiriSophie LiabeufFrançois BrazierAlban NowakYoussef BennisSolène M LavilleSandra BodeauValérie Gras-ChampelKamel MasmoudiGabriel ChoukrounBenjamin BatteuxPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2023)
Even though the lipid profile improved, statin exposure was not associated with a decrease in CV events in this real-life, single-center, retrospective, long-term follow-up study of a KTR cohort. Larger, controlled studies are needed to confirm or refute these results.